FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2886381549> ?p ?o ?g. }

• W2886381549 endingPage "792" @default.
• W2886381549 startingPage "782" @default.
• W2886381549 abstract "Background Invasive pulmonary aspergillosis typically occurs in an immunocompromised host. For almost a century, influenza has been known to set up for bacterial superinfections, but recently patients with severe influenza were also reported to develop invasive pulmonary aspergillosis. We aimed to measure the incidence of invasive pulmonary aspergillosis over several seasons in patients with influenza pneumonia in the intensive care unit (ICU) and to assess whether influenza was an independent risk factor for invasive pulmonary aspergillosis. Methods We did a retrospective multicentre cohort study. Data were collected from adult patients with severe influenza admitted to seven ICUs across Belgium and The Netherlands during seven influenza seasons. Patients were older than 18 years, were admitted to the ICU for more than 24 h with acute respiratory failure, had pulmonary infiltrates on imaging, and a confirmed influenza infection based on a positive airway PCR test (influenza cohort). We used logistic regression analyses to determine if influenza was independently associated with invasive pulmonary aspergillosis in non-immunocompromised (ie, no European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group [EORTC/MSG] host factor) influenza-positive patients (influenza case group) compared with non-immunocompromised patients with severe community-acquired pneumonia who had a negative airway influenza PCR test (control group). Findings Data were collected from patients admitted to the ICU between Jan 1, 2009, and June 30, 2016. Invasive pulmonary aspergillosis was diagnosed in 83 (19%) of 432 patients admitted with influenza (influenza cohort), a median of 3 days after admission to the ICU. The incidence was similar for influenza A and B. For patients with influenza who were immunocompromised, incidence of invasive pulmonary aspergillosis was as high as 32% (38 of 117 patients), whereas in the non-immunocompromised influenza case group, incidence was 14% (45 of 315 patients). Conversely, only 16 (5%) of 315 patients in the control group developed invasive pulmonary aspergillosis. The 90-day mortality was 51% in patients in the influenza cohort with invasive pulmonary aspergillosis and 28% in the influenza cohort without invasive pulmonary aspergillosis (p=0·0001). In this study, influenza was found to be independently associated with invasive pulmonary aspergillosis (adjusted odds ratio 5·19; 95% CI 2·63–10·26; p<0·0001), along with a higher APACHE II score, male sex, and use of corticosteroids. Interpretation Influenza was identified as an independent risk factor for invasive pulmonary aspergillosis and is associated with high mortality. Future studies should assess whether a faster diagnosis or antifungal prophylaxis could improve the outcome of influenza-associated aspergillosis. Funding None." @default.
• W2886381549 created "2018-08-22" @default.
• W2886381549 creator A5001356671 @default.
• W2886381549 creator A5016288132 @default.
• W2886381549 creator A5027100719 @default.
• W2886381549 creator A5027744692 @default.
• W2886381549 creator A5042023175 @default.
• W2886381549 creator A5049053496 @default.
• W2886381549 creator A5052550074 @default.
• W2886381549 creator A5055148071 @default.
• W2886381549 creator A5055321140 @default.
• W2886381549 creator A5059033441 @default.
• W2886381549 creator A5061617800 @default.
• W2886381549 creator A5064822409 @default.
• W2886381549 creator A5067273110 @default.
• W2886381549 creator A5067409619 @default.
• W2886381549 creator A5074930464 @default.
• W2886381549 creator A5074969792 @default.
• W2886381549 creator A5075304288 @default.
• W2886381549 creator A5080572049 @default.
• W2886381549 creator A5085769026 @default.
• W2886381549 creator A5086646404 @default.
• W2886381549 creator A5089595715 @default.
• W2886381549 date "2018-10-01" @default.
• W2886381549 modified "2023-10-18" @default.
• W2886381549 title "Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study" @default.
• W2886381549 cites W1599702287 @default.
• W2886381549 cites W1979876628 @default.
• W2886381549 cites W2000059657 @default.
• W2886381549 cites W2017138972 @default.
• W2886381549 cites W2026230041 @default.
• W2886381549 cites W2039267791 @default.
• W2886381549 cites W2071298942 @default.
• W2886381549 cites W2076298858 @default.
• W2886381549 cites W2082695689 @default.
• W2886381549 cites W2083513831 @default.
• W2886381549 cites W2099425916 @default.
• W2886381549 cites W2108396393 @default.
• W2886381549 cites W2121912067 @default.
• W2886381549 cites W2140505203 @default.
• W2886381549 cites W2146455307 @default.
• W2886381549 cites W2166734004 @default.
• W2886381549 cites W2167423543 @default.
• W2886381549 cites W2306301618 @default.
• W2886381549 cites W2346946071 @default.
• W2886381549 cites W2402456610 @default.
• W2886381549 cites W2470291098 @default.
• W2886381549 cites W2505395886 @default.
• W2886381549 cites W2508794604 @default.
• W2886381549 cites W2528694892 @default.
• W2886381549 cites W2564915973 @default.
• W2886381549 cites W2589347108 @default.
• W2886381549 cites W2605187611 @default.
• W2886381549 cites W2716497157 @default.
• W2886381549 cites W2741940869 @default.
• W2886381549 cites W2803962224 @default.
• W2886381549 doi "https://doi.org/10.1016/s2213-2600(18)30274-1" @default.
• W2886381549 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30076119" @default.
• W2886381549 hasPublicationYear "2018" @default.
• W2886381549 type Work @default.
• W2886381549 sameAs 2886381549 @default.
• W2886381549 citedByCount "582" @default.
• W2886381549 countsByYear W28863815492018 @default.
• W2886381549 countsByYear W28863815492019 @default.
• W2886381549 countsByYear W28863815492020 @default.
• W2886381549 countsByYear W28863815492021 @default.
• W2886381549 countsByYear W28863815492022 @default.
• W2886381549 countsByYear W28863815492023 @default.
• W2886381549 crossrefType "journal-article" @default.
• W2886381549 hasAuthorship W2886381549A5001356671 @default.
• W2886381549 hasAuthorship W2886381549A5016288132 @default.
• W2886381549 hasAuthorship W2886381549A5027100719 @default.
• W2886381549 hasAuthorship W2886381549A5027744692 @default.
• W2886381549 hasAuthorship W2886381549A5042023175 @default.
• W2886381549 hasAuthorship W2886381549A5049053496 @default.
• W2886381549 hasAuthorship W2886381549A5052550074 @default.
• W2886381549 hasAuthorship W2886381549A5055148071 @default.
• W2886381549 hasAuthorship W2886381549A5055321140 @default.
• W2886381549 hasAuthorship W2886381549A5059033441 @default.
• W2886381549 hasAuthorship W2886381549A5061617800 @default.
• W2886381549 hasAuthorship W2886381549A5064822409 @default.
• W2886381549 hasAuthorship W2886381549A5067273110 @default.
• W2886381549 hasAuthorship W2886381549A5067409619 @default.
• W2886381549 hasAuthorship W2886381549A5074930464 @default.
• W2886381549 hasAuthorship W2886381549A5074969792 @default.
• W2886381549 hasAuthorship W2886381549A5075304288 @default.
• W2886381549 hasAuthorship W2886381549A5080572049 @default.
• W2886381549 hasAuthorship W2886381549A5085769026 @default.
• W2886381549 hasAuthorship W2886381549A5086646404 @default.
• W2886381549 hasAuthorship W2886381549A5089595715 @default.
• W2886381549 hasBestOaLocation W28863815492 @default.
• W2886381549 hasConcept C120665830 @default.
• W2886381549 hasConcept C121332964 @default.
• W2886381549 hasConcept C126322002 @default.
• W2886381549 hasConcept C167135981 @default.
• W2886381549 hasConcept C177713679 @default.
• W2886381549 hasConcept C203014093 @default.
• W2886381549 hasConcept C2776376669 @default.

• next